RGEN - Company ID 0000730272
REPLIGEN CORP (RGEN) reported revenue of $738.26M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $738.26M | +16.4% |
| FY 2024 | $634.44M | +0.3% |
| FY 2023 | $632.36M | -21.1% |
| FY 2022 | $801.54M | +19.5% |
| FY 2021 | $670.53M | +83.1% |
| FY 2020 | $366.26M | +35.5% |
| FY 2019 | $270.25M | +39.3% |
| FY 2018 | $194.03M | +37.4% |
| FY 2017 |
REPLIGEN CORP (RGEN) reported revenue of $738.26M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, REPLIGEN CORP's revenue grew from $27.29M to $738.26M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $141.24M |
| +35.1% |
| FY 2016 | $104.54M | +25.1% |
| FY 2015 | $83.54M | +31.5% |
| FY 2014 | $63.55M | -6.8% |
| FY 2013 | $68.17M | +9.5% |
| FY 2012 | $62.27M | +128.2% |
| FY 2011 | $27.29M | - |